1. Home
  2. CRDF vs PRE Comparison

CRDF vs PRE Comparison

Compare CRDF & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDF
  • PRE
  • Stock Information
  • Founded
  • CRDF 1999
  • PRE 2014
  • Country
  • CRDF United States
  • PRE Hong Kong
  • Employees
  • CRDF N/A
  • PRE N/A
  • Industry
  • CRDF Biotechnology: Biological Products (No Diagnostic Substances)
  • PRE Biotechnology: Laboratory Analytical Instruments
  • Sector
  • CRDF Health Care
  • PRE Industrials
  • Exchange
  • CRDF Nasdaq
  • PRE Nasdaq
  • Market Cap
  • CRDF 144.4M
  • PRE 131.3M
  • IPO Year
  • CRDF N/A
  • PRE N/A
  • Fundamental
  • Price
  • CRDF $2.22
  • PRE $17.25
  • Analyst Decision
  • CRDF Strong Buy
  • PRE Buy
  • Analyst Count
  • CRDF 5
  • PRE 1
  • Target Price
  • CRDF $11.10
  • PRE $9.00
  • AVG Volume (30 Days)
  • CRDF 859.9K
  • PRE 119.9K
  • Earning Date
  • CRDF 11-06-2025
  • PRE 11-26-2025
  • Dividend Yield
  • CRDF N/A
  • PRE N/A
  • EPS Growth
  • CRDF N/A
  • PRE N/A
  • EPS
  • CRDF N/A
  • PRE N/A
  • Revenue
  • CRDF $545,000.00
  • PRE $57,051,000.00
  • Revenue This Year
  • CRDF N/A
  • PRE $202.46
  • Revenue Next Year
  • CRDF N/A
  • PRE $103.60
  • P/E Ratio
  • CRDF N/A
  • PRE N/A
  • Revenue Growth
  • CRDF N/A
  • PRE 151.74
  • 52 Week Low
  • CRDF $1.90
  • PRE $3.10
  • 52 Week High
  • CRDF $5.64
  • PRE $17.50
  • Technical
  • Relative Strength Index (RSI)
  • CRDF 50.17
  • PRE 69.66
  • Support Level
  • CRDF $2.10
  • PRE $14.50
  • Resistance Level
  • CRDF $2.33
  • PRE $17.45
  • Average True Range (ATR)
  • CRDF 0.12
  • PRE 1.33
  • MACD
  • CRDF 0.01
  • PRE 0.08
  • Stochastic Oscillator
  • CRDF 37.82
  • PRE 88.90

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.

About PRE Prenetics Global Limited

Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.

Share on Social Networks: